Globe Newswire
Strong survival data extending to 90 days
Real-world experience shows results consistent with clinical trial data
Favorable safety profile – no device-related adverse events
DENVER, Feb. 09, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today the publication of early post-approval clinical experience from the use of the QUELIMMUNE (Selective Cytopheretic Device for Pediatrics, or... (continue reading...)
Join ParaZero at Enforce Tac 2026 Israeli National Pavilion and See its Proven Counter-Drone Technology - Contact ParaZero to Arrange a Private Meeting
Kfar Saba, Israel, Feb. 09, 2026 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, today announced its participation in Enforce Tac 2026,... (continue reading...)
Join ParaZero at Enforce Tac 2026 Israeli National Pavilion and See its Proven Counter-Drone Technology - Contact ParaZero to Arrange a Private Meeting
Kfar Saba, Israel, Feb. 09, 2026 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, today announced its participation in Enforce Tac 2026,... (continue reading...)
The Board of Directors of Kvika banki hf. is set to approve the financial statements of the Group for the year 2025 at a board meeting on Wednesday 11 February. The financial statements will subsequently be published after the domestic market has closed.
A meeting to present the results to shareholders and market participants will be held the next day, at 08:30 on Thursday 12 February, at the bank's headquarters on the 9th floor at Katrínartún 2, where Ármann... (continue reading...)
Vancouver, Canada, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced additional positive safety topline results from the second cohort of its ongoing FDA-approved Phase I/IIa clinical trial evaluating CMND-100, the... (continue reading...)
More Globe Newswire
View Older Stories-
Clearmind Medicine Announces Additional Topline Positive Safety Results Reinforcing Favorable Profile of CMND-100 in Ongoing Phase I/IIa Clinical Trial
-
SVCV Launches NextRock Investment Group as the Flagship Financial Firm and Global Asset Manager for the Group
-
Cygnet.One Approved as an AWS Amazon ECS Service Delivery Partner
-
Lil Wayne Performs Halftime Show in Hit Mobile Game Clash Royale
-
Badger Infrastructure Solutions Ltd. Confirms Release Date for Fourth Quarter 2025 Results
-
Turbo Energy Strengthens Financial Position Through Long-Term Bank Financing Restructuring
-
Atico Mining Update on Permitting Process for the La Plata Project in Ecuador
-
Bunker Hill Announces C$30 Million Brokered LIFE Offering of Units & Warrant Exercise, and Reverse Stock Split
-
Bunker Hill Announces C$30 Million Brokered LIFE Offering of Units & Warrant Exercise, and Reverse Stock Split
-
Reliance Global Group Signs Definitive Agreement to Acquire Controlling Stake in Post-Quantum Cybersecurity Company Enquantum
-
Klinikum Fürth Establishes Leading Robotic Heart Arrhythmia Program
-
Omni Bridgeway Releases 2Q26 Portfolio Update with Excellent Completion Metrics
-
Terra Innovatum Global Completes Process to Secure Full End-to-End Supply Chain Components for SOLO™ Micro-Modular Reactor, Demonstrating Build-Ready Execution
-
Yuki Joins AWS ISV Accelerate (ISVA) Program to Bring Real-Time Data Cost Control to AI Workloads on Snowflake
-
American Rare Earths’ Shareholder Letter
-
Form 8.3 -Avadel Pharmaceuticals plc
-
HUB Cyber Security Ltd. Launches SecureRide™ Trust Infrastructure for the $400B+ Global Rideshare Market
-
Phemex introduces 24/7 TradFi futures trading with 0-Fee Carnival, creating an all-in-one trading hub
-
WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY NOTIFICATION OF CHANGE IN THE INDEX METHODOLOGY - WENT & WATT
-
Kea Neobanking Group Heads to Consensus 2026 to Bridge the East-West Gap with its "Human-Touch" Banking Model
-
Celldex to Present at Upcoming Investor Conferences
-
Humacyte Announces New U.S. Department of Defense Funding for Procurement of Bioengineered Blood Vessels
-
Locke’s Air Conditioning Tallahassee, FL Announces Status as Lennox® Approved Dealer
-
Trained Therapeutix Discovery Appoints Distinguished Industry Leaders to its Board of Directors
-
Kea Neobanking Group Heads to Consensus 2026 to Bridge the East-West Gap with its "Human-Touch" Banking Model
-
IN8bio Promotes Kate Rochlin, Ph.D., to President and Chief Operating Officer
-
Major shareholder announcement
-
Ascentage Pharma to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026
-
Dufferin West Exploration Program Advances as Geophysical Team Mobilizes
-
The Oxford-Harrington Rare Disease Centre Advances Discovery of Therapies for Friedreich’s Ataxia (FA)
-
XBP Global Named to Newsweek’s America’s Greatest Workplaces for Culture, Belonging & Community 2026
-
Stoneway Agency Expands Partnership With Subtle Bodies to Lead Product Development and Reformulation
-
AMPLIFY Tracks Supreme Court Cruise Case With Major Implications for Cruise-Ship Injury and Maritime Liability
-
Billings Homebuyers Announces 3-Step Home Selling Process in Billings, MT
-
Flywire to Announce Fourth Quarter 2025 Results on February 24, 2026
-
Savaria announces the acquisition of Baxter Residential Elevators
-
ADT Announces Inclusion in the S&P SmallCap 600® Index
-
Voyager to Present at Upcoming Investor Conferences
-
Krystal Biotech Announces RMAT Designation Granted by FDA to KB707 for the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer
-
NOVAGOLD & Paulson Select Fluor as Donlin Gold’s Partner to Lead Bankable Feasibility Study
-
Aerska Raises $39M Series A Financing led by EQT Dementia Fund and age1 to Systemically Deliver RNA Medicines to the Brain
-
ORYZON Announces First Patient Dosed in an Investigator-Initiated Phase Ib Study of Iadademstat in Extensive Stage Small Cell Lung Cancer
-
NOVAGOLD & Paulson Select Fluor as Donlin Gold’s Partner to Lead Bankable Feasibility Study
-
Streamex Corp. (NASDAQ: STEX) Appoints Morgan Lekstrom as Executive Chairman, and Announces Completed Repayment of Convertible Debenture and Cancellation of SEPA
-
Verrica Pharmaceuticals Announces Launch of YCANTH® for the Treatment of Molluscum Contagiosum in Japan by Partner Torii Pharmaceutical
-
Mint Signed MoU with Robotics Leader Rice Robotics to Pioneer Physical AI Solutions Across Asia
-
Greenridge Global: Sapience AI Investment Represents a Big Deal for Society Pass Incorporated (Nasdaq: SOPA) Shareholders
-
XBP Global Named to Newsweek’s America’s Greatest Workplaces for Culture, Belonging & Community 2026
-
Kaltura to Announce Financial Results for Fourth Quarter and Full Year 2025 on Monday, March 16, 2026
-
Aether Holdings Launches SentimenTracker, Expanding Institutional-Grade Trading Toolset for Retail Investors
